CNS Pharmaceuticals - 54 Year Dividend History | CNSP
Historical dividend payout and yield for CNS Pharmaceuticals (CNSP) since 1971. The current TTM dividend payout for CNS Pharmaceuticals (CNSP) as of February 21, 2025 is $0.00. The current dividend yield for CNS Pharmaceuticals as of February 21, 2025 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.004B |
$0.000B |
|
CNS Pharmaceuticals Inc. is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors. The company's lead drug includes Berubicin, for the treatment of Glioblastoma Multiforme and potentially for other CNS malignancies. CNS Pharmaceuticals Inc. is based in Houston, United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
